GLP-1 weight loss medications: Providers can prescribe brand-name GLP-1 agonist medications, including Wegovy and Zepbound, ...

Getting your heart rate up is integral for longevity—regular exercise has been shown to lower your risk of type 2 diabetes, heart disease, and a slew of other health conditions. It’s also key for ...

Every few years, the concept of fasted exercise training pops up all over social media. Fasted training refers to exercising in the morning, before eating breakfast. Fans will claim it's the most ...

While Ozempic and other drugs like it have proven effective in helping people lose weight, many gain it back when the injections stop. A new drug targets weight loss differently, leading to a more ...

Watch the full conversation with Dr. Shawn Baker as we break down how to personalize the carnivore diet for your unique health goals. Whether you're battling brain fog or burning fat, this could be a ...

What’s feeding your hunger? New research suggests that your motivation for eating that second slice of pizza could influence how well you respond to blockbuster GLP-1s like Ozempic and Wegovy. The ...

VIENNA — Exercise to maintain weight loss reduced atherosclerosis progression and improved cardiovascular biomarkers, while GLP-1 therapy alone didn’t, according to a randomized trial in people with ...

According to Manchester legend Ricky Hatton, former heavyweight world champion Tyson Fury (25-0, 18 KOs) has lost weight and is once again very fast on his feet. At his Lancashire facility, Hatton has ...

FDA's new voucher could shorten drug review to 1-2 months Lilly's orforglipron targets high-burden chronic condition Analysts predict price erosion due to new market entrants Sept 16 (Reuters) - Eli ...

Researchers at Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital, Stanford University School of Medicine and collaborating ...

Over the last four years, weight-loss drugs that dampen down appetite and promote satiety have revolutionised obesity medicine. They are currently being taken by 1.5 million people in the UK and have ...

Martin Whyte does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...